{"title":"Review: Haloperidol, fluphenazine, clozapine show poor results on cognition","authors":"","doi":"10.1002/pu.31261","DOIUrl":null,"url":null,"abstract":"<p>A systematic review and network meta-analysis encompassing 68 randomized trials has concluded that the antipsychotics haloperidol, fluphenazine, and clozapine ranked lowest on measures of cognition in patients with schizophrenia and related disorders. There were few clear differences overall among the antipsychotics studied, the investigators reported. Results were published online Oct. 16, 2024, in <i>JAMA Psychiatry</i>.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 2","pages":"1-6"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31261","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
A systematic review and network meta-analysis encompassing 68 randomized trials has concluded that the antipsychotics haloperidol, fluphenazine, and clozapine ranked lowest on measures of cognition in patients with schizophrenia and related disorders. There were few clear differences overall among the antipsychotics studied, the investigators reported. Results were published online Oct. 16, 2024, in JAMA Psychiatry.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
